July 29, 2021
RegMed Investors’ (RMi) closing bell: in the blink of an eye or a mid-day dive, the oversold became the overbought
July 28, 2021
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector snapped, crackled and popped
July 27, 2021
RegMed Investors’ (RMi) closing bell: wipeout with low extremely volume
July 22, 2021
RegMed Investors’ (RMi) closing bell: key word, expectation was subjugated by another move to another extreme downside
July 21, 2021
RegMed Investors’ (RMi) closing bell: whip saw behavior
July 19, 2021
RegMed Investors’ (RMi) closing bell: to start the week, a crash with blood on the street as sector breadth spilled red
July 16, 2021
RegMed Investors’ (RMi) closing bell: weakness stimulates fluctuations in sector performance
July 16, 2021
RegMed Investors’ (RMi) closing bell: weakness stimulates fluctuations in sector performance
July 15, 2021
RegMed Investors’ (RMi) closing bell: the challenge, when to BUY the dips?
July 15, 2021
RegMed Investors’ (RMi) closing bell: the challenge, when to BUY the dips?
July 14, 2021
RegMed Investors’ (RMi) closing bell: back to staring into the abyss
July 14, 2021
RegMed Investors’ (RMi) closing bell: back to staring into the abyss
July 13, 2021
RegMed Investors’ (RMi) closing bell: the ceiling collapsed taking sector share pricing plunging again
July 12, 2021
RegMed Investors’ (RMi) closing bell: feeling the squeeze of sentiment
July 9, 2021
RegMed Investors’ (RMi) closing bell: yet another comeback to our upside delight in a changing July
July 8, 2021
RegMed Investors’ (RMi) closing bell: past downslide is an upside for some cell and gene therapy equities
July 7, 2021
RegMed Investors’ (RMi) closing bell: fear while staring down the cell and gene therapy sector abyss
July 3, 2021
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector collapsed after a sloppy week
July 1, 2021
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector bounces after Wednesday’s slight slippage
June 30, 2021
RegMed Investors’ (RMi) closing bell: could have been worse
June 29, 2021
RegMed Investors’ (RMi) closing bell: it was programmed to happen
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2021 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.